Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank of Montreal (BMO) vs BIO-TECHNE Corp (TECH) Price & Performance

Bank of MontrealTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

Bank of Montreal vs BIO-TECHNE Corp — how do they compare? Bank of Montreal trades at $180.98 (market cap $124.81B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Bank of Montreal is far larger — about 11.2× BIO-TECHNE Corp's market cap, and Bank of Montreal pays the higher dividend (2.77%). Which is the better fit depends on your goals.

BMOTECH
Market Cap
$124.81B$11.12B
Sector
FinancialsHealth
52-Week High
$180.86$71.38
52-Week Low
$110.44$43.31
Dividend Yield
2.77%0.45%
Enterprise Value
$11.20B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bank of Montreal

Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.

Read more on BMO

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH